MetaCap

Sera Prognostics Statistics

NASDAQ: SERAHealth CareMedical SpecialitiesUSD

1.81-0.08 (-4.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Sera Prognostics by the numbers

Sera Prognostics has a market capitalization of $72.0 million based on 38.80M shares outstanding. With trailing EPS of $-0.67, Sera Prognostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.9% below its 50-day average and 11.7% below its 200-day average.

Average daily trading volume is 27.84K shares, or about $50,394 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SERA valuation vs. peer median

SERA compared with the median of 8 peer companies
MetricSERAPeer medianDifference
Market cap$71.98M$47.04M+53%
Avg. volume27.84K62.45K-55%

Peer median across 8 companies: BDSX, XGN, KEQU, MDXH, AMS, BNR, ACON, ADVB.

Valuation

Market cap
$71.98M
Price / sales (latest FY)
888.68
EPS (TTM)
$-0.67

Price and trading

Previous close
1.89
Open
1.82
Day range
1.80 – 1.87
52-week range
1.56 – 3.85
52-week change
-43.96%
Beta
—
Volume
94.60K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
71.98M
Forward Pe
-3.18
Eps
-0.67
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.85
Week52 Low
1.56
Avg Volume
27,842.00
Shares Outstanding
38.80M
Ma50
2.03
Ma200
2.05
Earnings Date
Nov 4, 2026
Pct From52w High
-52.99%
Pct From52w Low
16.03%

Related